The lack of association between JAK2 V617F mutation and myelodysplastic syndrome with or without myelofibrosis

Leukemia. 2006 Jun;20(6):1165. doi: 10.1038/sj.leu.2404196.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Cohort Studies
  • Diagnosis, Differential
  • Follow-Up Studies
  • Humans
  • Janus Kinase 2
  • Myelodysplastic Syndromes / complications*
  • Myelodysplastic Syndromes / diagnosis
  • Myelodysplastic Syndromes / genetics*
  • Myeloproliferative Disorders / diagnosis*
  • Point Mutation*
  • Primary Myelofibrosis / complications*
  • Primary Myelofibrosis / diagnosis
  • Primary Myelofibrosis / genetics*
  • Prognosis
  • Protein-Tyrosine Kinases / genetics*
  • Proto-Oncogene Proteins / genetics*
  • Survival Rate

Substances

  • Proto-Oncogene Proteins
  • Protein-Tyrosine Kinases
  • JAK2 protein, human
  • Janus Kinase 2